U.S., Sept. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07797673) titled 'Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia' on Aug. 23.
Brief Summary: Biliary atresia is a progressive liver disease in infants where liver transplantation is often the only long-term option once cirrhosis develops. However, organ shortages, high costs, risks of graft rejection, and the need for lifelong immunosuppression make transplantation difficult for many families. This double-blind randomized clinical trial evaluates whether injecting umbilical cord-mesenchymal stem cells directly into the liver during Kasai portoenterostomy is safe and effective as an additional treatment. Umbilical cord stem cells hav...